FDA Brief

Company record

Reset IV, LLC dba Reset IV

1 FDA warning letter since 2023 and 0 recalls in the last 12 months.

Get an email the day FDA posts anything new about Reset IV, LLC dba Reset IV.

Warning letters

  1. Reset IV, LLC dba Reset IV

    FDA warned Reset IV that its website misbrands compounded semaglutide and tirzepatide by claiming they are the same as FDA-approved drugs.

    Medium